A method for assessing the sensitivity of a patient's tumor cells to cephalomannine and 10-deacetyltaxol in order to treat those tumor cells involves the removal of a sample of the tumor cells and establishing a cell line therefrom. Cells from the cell line are cultured and then contacted with varying concentrations of cephalomannine or 10-deacetyltaxol to form treated cells. The treated cells are assessed to determine the cytotoxic effect of the cephalomannine and/or the 10-deacetyltaxol and, where cytotoxic response is exhibited, a therapeutic dosage is formulated using the selected concentration of cephalomannine or 10-deacetyltaxol and a carrier material. The method is particularly useful for neural and glial tumor cells.

NaPro BioTherapeutics, Inc.

Method for assessing sensitivity of tumor cells to cephalomannine and 10-deacetyltaxol

Provided are novel paclitaxel analogues, namely selectively brominated stereospecific derivatives of cephalomannine and 7-epi-cephalomannine having in vivo and in vitro paclitaxel-like antitumor efficacy, methods of preparation therefor and methods for treating tumors with these compounds.

cephalomannine/neoplasms

Method for assessing sensitivity of tumor cells to cephalomannine and 10-deacetyltaxol

Preparation of brominated paclitaxel analogues and their use as effective antitumor agents

Cea mai completă bază de date cu plante medicinale susținută de știință